JP Morgan Maintains Overweight on Nutrien, Raises Price Target to $80

Benzinga Newsdesk www.benzinga.com Positive 77.1%

Neg 0% Neu 0% Pos 77.1%

JP Morgan analyst Jeffrey Zekauskas maintains Nutrien (NYSE:NTR) with a Overweight and raises the price target from $78 to $80.